Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML).

MLA

Scherr, Michaela, et al. “Enhanced Sensitivity to Inhibition of SHP2, STAT5, and Gab2 Expression in Chronic Myeloid Leukemia (CML).” Blood, vol. 107, no. 8, Apr. 2006, pp. 3279–87. EBSCOhost, https://doi.org/10.1182/blood-2005-08-3087.

APA

Scherr, M., Chaturvedi, A., Battmer, K., Dallmann, I., Schultheis, B., Ganser, A., & Eder, M. (2006). Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML). Blood, 107(8), 3279–3287. https://doi.org/10.1182/blood-2005-08-3087

Chicago

Scherr, Michaela, Anuhar Chaturvedi, Karin Battmer, Iris Dallmann, Beate Schultheis, Arnold Ganser, and Matthias Eder. 2006. “Enhanced Sensitivity to Inhibition of SHP2, STAT5, and Gab2 Expression in Chronic Myeloid Leukemia (CML).” Blood 107 (8): 3279–87. doi:10.1182/blood-2005-08-3087.